The public has more confidence in the American Heart Association than it does in the FDA, CMS or any other federal health agencies. 

A team of legal and medical experts conducted a mock trial that entailed a series of hypothetical cases involving AI, sharing their findings in Nature Health. 

Lantheus expects the reformulated agent to be commercially available by the fourth quarter of 2026. 

The new-look device was designed to deliver 10 pulses to severely calcified coronary lesions in five seconds. Early data linked the catheter with positive 30-day safety and effectiveness outcomes.

Burnout remains one of the biggest issues in modern healthcare. More than 1,500 surgeons, including many from the field of cardiac surgery, provided feedback for a new report on that very topic. 

Scientia Vascular, a Salt Lake City-based medtech company focused on developing new vascular devices, was founded in 2007 and has more than 300 employees.

As more healthcare organizations rely on AI to interpret imaging, ECRI is urging leaders to take “a balanced approach to adoption.” 

Utilizing data from the Texas STAR database, researchers believe this is one of the first such studies to assess trends in radiology residency applications post-pandemic. 

The regulatory decision applies to GEHC’s View, a key piece of the Chicago-based company’s Genesis Radiology Workspace.